 This study found that dexmodetamidine provided better hemodynamic control and was associated with lesser blood loss without any significant adverse effects when compared to propofol for use as a hypotensive agent during functional endoscopic sinus surgery, FESS. This article was authored by Kevol Krishan Gupta, Vandana Kumari, Sarvjeet Kaur and others.